# Contact Tirzepatide Script — Editorial Enquiries

> Contact Tirzepatide Script with corrections, source suggestions, or editorial enquiries. This site does not provide medical advice. Tirzepatide is an FDA-approved medicine; consult a licensed physician.

## Contact

Tirzepatide Script is an independent editorial publication. We welcome:

- Factual corrections to cited claims
- Suggestions for studies we have not covered
- Requests for clarification on editorial methodology
- General enquiries about the site

We do not provide medical advice, clinical consultations, or referrals. Tirzepatide is an FDA-approved prescription medicine. Questions about whether it is appropriate for any individual belong with a licensed medical professional, not with this site.

Use the form below to reach the editorial team. We aim to respond to corrections within five business days.

---

*Tirzepatide Script: an independent editorial record of the dual-incretin research literature. Not a clinic, not a vendor, not a source of clinical advice.*

---

An independent editorial record of what the SURPASS and SURMOUNT trials — and the mechanistic studies behind them — actually measured.